1011.HK Stock Analysis
10
Uncovered
China NT Pharma Group Company Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
China NT Pharma Group Co., Ltd. is a pharmaceutical company, which engages in the distribution, promotion, manufacturing as well as research and development of pharmaceuticals and vaccines. The company is headquartered in Suzhou, Jiangsu and currently employs 190 full-time employees. The company went IPO on 2011-04-20. The firm mainly conducts its businesses through two segments. The Proprietary Product Production and Sales segment is engaged in the production and sales of NT branded products and generic drugs through its subsidiaries. The Miacalcic segment is engaged in the sales and marketing of miacalcic injectable and nasal spray branded products for treatment of bone pain caused by osteolysis and lower bone mass, as well as sub-licensing of intellectual property rights and distribution rights.